by Rod Raynovich | Oct 23, 2009 | BIOgraph
We commented on Tuesday about the broad selling of all biotech stocks large and small and this trend continues through today. AMGN shares are down this week despite earnings EPS of $1.49 beating estimates of $1.27 as regulatory concerns about its experimental...
by Rod Raynovich | Oct 20, 2009 | BIOgraph
Biotech stocks were in a broad retreat today for reasons that are not yet apparent as the Nasdaq and S&P were only down a modest 0.6%. Large caps that were hard hit include AMGN, BIIB,and VRTX as well as the major ETF’s IBB and XBI. My broad index of 35 mid...
by Rod Raynovich | Oct 7, 2009 | BIOgraph
Biotech summer rally sparked by deals Life Science stocks kept pace with market sectors that offer comparable risk and performance: Small cap growth, science and technology and midcap growth. The bellwether, broadly diversified ETF IBB was up 16% moving from 70 to 81...
by Rod Raynovich | Oct 2, 2009 | BIOgraph
The CDC provided a situation update regarding key flu indicators for the Week of Sep 20-26 and said that influenza activity remained elevated in virtually all states. Visits to doctors and hospitals are higher than can be expected this time of the year and almost all...
by Rod Raynovich | Oct 2, 2009 | Macro
The dollar traded down 0.38% after a fierce rally yesterday that coincided with a weak stock market. Crude fell 1.5% today to $69.77 a barrel with weak employment number and assumption that energy demand will take a long time to rebound. Unemployment rose to a 26 year...
by Rod Raynovich | Oct 1, 2009 | Energy, Macro
The market took a thrashing today with the biggest one day slide since July 2; major indices were down 2-3% but materials and financials were down 4%. The Dollar Index DXY was up 0.7% to 77.2% just off its one year low of 75. Equities have been tracking the dollar and...
